Ipca Laboratories Ltd Annually Results

Gross Sales

8,939.59

7,705.04

6,244.32

5,829.79

5,419.99

Excise Duty

0

0

0

0

0

Net Sales

8,939.59

7,705.04

6,244.32

5,829.79

5,419.99

Other Operating Income

0

0

0

0

0

Other Income

92.8

124.77

125.62

66.57

62.84

Total Income

9,032.39

7,829.81

6,369.94

5,896.36

5,482.83

Total Expenditure

7,418.5

6,491.63

5,317.55

4,520.53

3,875.64

PBIDT

1,613.89

1,338.18

1,052.39

1,375.83

1,607.19

Interest

84.93

138.27

45.54

7.69

9.04

PBDT

1,528.96

1,199.91

1,006.85

1,368.14

1,598.15

Depreciation

397.82

357.24

261.56

232.42

209.17

Minority Interest Before NP

0

0

0

0

0

Tax

372.05

310.18

230.36

207.51

248.64

Deferred Tax

-28.44

3.28

23

17.26

-8.5

Reported Profit After Tax

787.53

529.21

491.93

910.95

1,148.84

Minority Interest After NP

47.56

-24.43

7.67

5.71

1.13

Net Profit after Minority Interest

737.68

547.35

471.32

884.08

1,140.01

Extra-ordinary Items

-137.61

-67.67

0

0

0

Adjusted Profit After Extra-ordinary item

875.29

615.02

471.32

884.08

1,140.01

EPS (Unit Curr.)

29.08

21.57

18.58

34.85

90.02

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

400

400

400

800

400

Equity

25.37

25.37

25.37

25.37

25.37

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

18.05

17.36

16.85

23.59

29.65

PBDTM(%)

17.1

15.57

16.12

23.46

29.48

PATM(%)

8.8

6.86

7.87

15.62

21.19